Cancer Biotherapy and Radiopharmaceuticals · 2011 · 32 citations · 17 references
Life SciencesNeuroscienceOncologyApoptosisCell SignalingMolecular OncologyBrain TumorsCancer Stem Cell BiologyCancer Stem CellsGlioblastomaNeural Stem Cell BiologyNeural Stem CellsBcl-xl FunctionCyclin D DysregulationTumor Initiating Cells
Glioma stem cells (GSCs), which are originated from transformed neural stem cells, are tumor-initiating cells of glioma, the most common primary malignant neoplasm of the central nervous system. Extensive studies have shown that bone morphogenetic protein 4 (BMP4) plays an important role in the differentiation and proliferation of neural stem cells. To seek the functions and mechanisms of BMP4 in GSCs, GSCs isolated from U87 human glioma cells by using vincristine were exposed to BMP4 protein. This study shows that BMP4 inhibited U87 GSC proliferation (p < 0.01) via downregulation of cyclin D1 level and promoted GSC apoptosis through induction of Bax expression and inhibition of Bcl-2 and Bcl-xL levels. Thus, these results indicate a new approach of GSC-based glioma treatment.
17
Identification of human brain tumour initiating cells
Sheila K. Singh, Cynthia Hawkins, Ian D. Clarke et al. · Nature · 2004 · 7.4K citations
Medicine, Cancer Biology, Oncology +11
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao, Qiulian Wu, Roger E. McLendon et al. · Nature · 2006 · 6.4K citations
Medicine, Cancer Biology, Oncology +16
Identification of a cancer stem cell in human brain tumors.
Sheila K. Singh, Ian D. Clarke, Mizuhiko Terasaki et al. · PubMed · 2003 · 4.9K citations
Medicine, Cell Biology, Oncology +17
Genetic Pathways to Glioblastoma
Hiroko Ohgaki, Pierre Dessen, Benjamin Jourde et al. · Cancer Research · 2004 · 1.3K citations · Full text
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
Sara Piccirillo, Brent A. Reynolds, Nadia Zanetti et al. · Nature · 2006 · 1.2K citations
Medicine, Cancer Biology, Oncology +14